Detalles de la búsqueda
1.
Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial.
Eur Urol
; 73(3): 427-435, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28705540
Resultados
1 -
1
de 1
1
Próxima >
>>